Theorem Implements SAS Clinical Data Integration to Save Sponsors Time and Resources and Ensure Quality
Theorem Clinical Research continues to broaden its ability to help sponsors optimize trial conduct
Theorem Clinical Research
continues to broaden its ability to help sponsors optimize trial conduct, recently implementing SAS® Clinical Data Integration (SAS CDI), an innovative solution that automates the process of transforming, managing and verifying the creation of industry-mandated data standards.
SAS enables Theorem to automate the mapping of standard electronic data capture (EDC) databases and external data into standard data sets that are compliant with the Clinical Data Interchange Standards Consortium (CDISC). By using the technology for routine tasks, Theorem can now more easily manage standards throughout the entire life cycle.
Additionally, SAS CDI will be leveraged to automate Theorem’s clinical data warehouse and highly visual data discovery tools, reducing time and effort to obtain clinical data in real time.
“As an early supporter of CDISC, Theorem recognized the value that standardization and harmonization would bring to clinical data and reporting,” said Mark Penniston, executive vice president of clinical analytics for Theorem. “Now we’re able to combine our deep experience in developing CDISC-compliant data domains with SAS technology to produce high-quality, standardized data sets faster and more efficiently.”
Kecia Serwin, vice president,
SAS Health Care and Life Sciences
, commented, “We’re delighted that Theorem has joined the list of leading life science organizations who’ve chosen SAS to streamline standards adoption in drug development processes.”
As a
CDISC Registered Solutions Provider,
Theorem was among the first global contract research organizations to execute a CDISC-compliant submission in 2004 and has created more than 50,000 CDISC-compliant data sets to date.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
